Yahoo Search Busca da Web

Resultado da Busca

  1. 3 de abr. de 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.

  2. Persistent coronavirus disease 2019 (covid-19) symptoms are increasingly well-reported in the literature. These persistent symptoms following acute infection, otherwise known as ‘long covid’, have affected people worldwide.

  3. 3 de out. de 2021 · Vaccines have greatly reduced the risk of severe infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reduce viral transmission. However, some individuals mount a weak response to vaccination, leaving them vulnerable and increasing the risk they present to others.

    • Saray Stancic, Josh Cullimore, Neal D. Barnard
    • 2021
  4. 6 de ago. de 2020 · Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection - The American Journal of Medicine. Review | Volume 134, ISSUE 1, P16-22, January 2021. Download Full Issue. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Peter A. McCullough, MD, MPH.

    • Peter A McCullough, Peter A McCullough, Ronan J Kelly, Gaetano Ruocco, Edgar Lerma, James Tumlin, Ke...
    • 2021
  5. 22 de set. de 2021 · Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel | New England Journal of Medicine. Original Article. Effectiveness of mRNA Covid-19 Vaccine among U.S. Health...

    • Tamara Pilishvili, Ryan Gierke, Katherine E Fleming-Dutra, Jennifer L Farrar, Nicholas M Mohr, David...
    • 2021
  6. 31 de ago. de 2022 · Franklin H. Epstein Lecture. Covid-19 Vaccines — Immunity, Variants, Boosters. Author: Dan H. Barouch, M.D., Ph.D. Author Info & Affiliations. Published August 31, 2022. N Engl J Med...

  7. 2 de abr. de 2020 · Coverage of latest information on COVID-19 from across the medical literature and put into context for you by NEJM Journal Watch editors. Articles. Filter by Date. Apr 10, 2024. |. Infectious Diseases. Hospital Medicine. Monoclonal Antibody Receives Emergency Use Authorization for Preventing COVID-19 in High-Risk Patients. Daniel Kaul, MD.